Inventor

Geoffrey Guy

Inventor

London, GB

Overview

2004–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 45 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes48%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations41%

B01DSeparation6%

A61MDevices for introducing media into, or onto, the body2%

A61FFilters implantable into blood vessels1%

A61JContainers specially adapted for medical or pharmaceutical purposes1%

B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers1%

PatentTitleYear

11,096,905Use of cannabinoids in the treatment of epilepsy2021 11,065,209Use of cannabidiol in the treatment of epilepsy2021 10,966,939Use of cannabinoids in the treatment of epilepsy2021 10,918,608Use of cannabidiol in the treatment of epilepsy2021 10,898,462Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders2021 10,849,860Use of cannabinoids in the treatment of epilepsy2020 10,765,643Use of cannabidiol in the treatment of epilepsy2020 10,709,671Use of cannabinoids in the treatment of epilepsy2020 10,709,673Use of cannabinoids in the treatment of epilepsy2020 10,709,674Use of cannabinoids in the treatment of epilepsy2020 10,653,641Use of cannabinoids in the treatment of mental disorders2020 10,603,288Use of cannabinoids in the treatment of epilepsy2020 10,583,096Use of cannabinoids in the treatment of epilepsy2020 10,258,580Cannabinoids for use in the treatment of neurodegenerative diseases or disorders2019 10,220,005Synergistic therapies of cannabidiol with hypothermia for neuroprotection2019 10,195,159Processes and apparatus for extraction of active substances and enriched extracts from natural products2019 10,137,095Use of cannabinoids in the treatment of epilepsy2018 10,111,840Use of cannabinoids in the treatment of epilepsy2018 10,092,525Use of cannabinoids in the treatment of epilepsy2018 10,004,684Pharmaceutical formulations2018 9,956,185Use of cannabinoids in the treatment of epilepsy2018 9,956,183Use of cannabinoids in the treatment of epilepsy2018 9,956,186Use of cannabinoids in the treatment of epilepsy2018 9,956,184Use of cannabinoids in the treatment of epilepsy2018 9,949,937Use of cannabinoids in the treatment of epilepsy2018 9,949,936Use of cannabinoids in the treatment of epilepsy2018 9,895,342'Cannabinoids for use in the treatment of neuropathic pain'2018 9,675,654'Phytocannabinoids in the treatment of cancer'2017 9,669,002'Use for cannabinoid'2017 9,522,123'Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy'2016 9,474,726'Use of cannabinoids in the treatment of epilepsy'2016 9,205,063'Cannabinoid-containing plant extracts as neuroprotective agents'2015 9,168,278'Use for cannabinoid'2015 9,066,920'Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy'2015 9,034,395'Processes and apparatus for extraction of active substances and enriched extracts from natural products'2015 9,017,737'Use of cannabinoids in combination with an anti-psychotic medicament'2015 8,790,719'Phytocannabinoids in the treatment of cancer'2014 8,771,760'Method for the treatment of constipation'2014 8,673,368'Cannabinoid-containing plant extracts as neuroprotective agents'2014 7,968,594'Pharmaceutical compositions for the treatment of pain'2011 7,622,140'Processes and apparatus for extraction of active substances and enriched extracts from natural products'2009 7,111,756'Dose dispensing apparatus'2006 7,025,992'Pharmaceutical formulations'2006 6,929,154'Secure dispensing apparatus'2005 6,730,330'Pharmaceutical formulations'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2020Patents assigned to GW PHARMA LTD (33)· patent assignee history

2005–2019Based in Salisbury, GB· patent location history

2009–2018Based in Dorchester, GB· patent location history

2014–2019Patents assigned to GUY GEOFFREY (9)· patent assignee history

2014–2017Patents assigned to OTSUKA PHARMA CO LTD (5)· patent assignee history

2014–2018Patents assigned to KIKUCHI TETSURO (4)· patent assignee history

2014–2015Based in Glanvilles Wootton, GB· patent location history

2016–2021Based in Cambridge, GB· patent location history

2018–2021Based in London, GB· patent location history

2019–2021Patents assigned to GW RES LTD (13)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
GW PHARMA LTD	33	2004–2020
GW RES LTD	13	2019–2021
GUY GEOFFREYself	9	2014–2019
OTSUKA PHARMA CO LTD	5	2014–2017
KIKUCHI TETSURO	4	2014–2018

Locations

Location	Patents	Span
London, GB	13	2018–2021
Salisbury, GB	12	2005–2019
Cambridge, GB	9	2016–2021
Dorchester, GB	2	2009–2018
Glanvilles Wootton, GB	2	2014–2015